Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference.
about
Melanoma-associated leukoderma - immunology in black and white?Concise review of recent studies in vitiligoRecent advances in understanding vitiligoImmune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.Increased Risk of Metabolic Syndrome in Patients with Vitiligo.A Multicenter Collaborative Study by the Korean Society of Vitiligo about Patients' Occupations and the Provoking Factors of VitiligoA case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat.Vitiligo--Part 2--classification, histopathology and treatmentCurrent Management of Pediatric Vitiligo.MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo.Vitiligo: an evidence-based update. Report of the 13th Evidence Based Update Meeting, 23 May 2013, Loughborough, U.K.Interferon-γ induces senescence in normal human melanocytes.Vitiligo treatment update.Effect of excimer laser treatment on vitiliginous areas with leukotrichia after confirmation by dermoscopy.Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo.Successful Repigmentation of Vitiligo after Allogeneic Bone Marrow Transplantation for Hodgkin's Lymphoma by Autologous Noncultured Melanocyte-keratinocyte Transplantation.Pattern of Childhood Onset Vitiligo at a Tertiary Care Centre in South- West Rajasthan.Autoimmune vitiligo is associated with gain-of-function by a transcriptional regulator that elevates expression of HLA-A*02:01 in vivo.Three new single nucleotide polymorphisms identified by a genome-wide association study in Korean patients with vitiligo.Autoimmune vitiligo in rheumatic disease in the mestizo Mexican population.Nail abnormalities in patients with vitiligo.Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells.Genetic polymorphism of the Nrf2 promoter region is associated with vitiligo risk in Han Chinese populationsOxidative stress-induced overexpression of miR-25: the mechanism underlying the degeneration of melanocytes in vitiligo.Clinical epidemiological profile of vitiligo in children and adolescents.Advances in Vitiligo: An Update on Medical and Surgical Treatments.Profile of vitiligo in kumaun region of uttarakhand, India.Which outcomes should we measure in vitiligo? Results of a systematic review and a survey among patients and clinicians on outcomes in vitiligo trials.Vitiligo: an update on current pharmacotherapy and future directions.Future horizons in vitiligo research: focusing on the recommendations of the Cochrane systematic review 'Interventions for vitiligo' 2010.Beyond vitiligo guidelines: combined stratified/personalized approaches for the vitiligo patient.Vitiligo: what's new in the psycho-neuro-endocrine-immune connection and related treatments.Narrowband ultraviolet B phototherapy in combination with other therapies for vitiligo: mechanisms and efficacies.Altered expression of four miRNA (miR-1238-3p, miR-202-3p, miR-630 and miR-766-3p) and their potential targets in peripheral blood from vitiligo patients.Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus Conference.Development and pilot testing of a vitiligo screening tool.Simultaneous improvement and worsening of vitiligo lesions during the course of NB-UVB phototherapy; vitiligo may not act as one unit.Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.Vitiligo on black skin: epidemiological and clinical aspects in dermatology, Cotonou (Benin).
P2860
Q26850001-62396809-32A3-44E0-8AB7-EC513D82B967Q27025963-0A5C4E5F-44C6-449E-8C37-5122E694C65AQ28078377-C1829055-1003-4892-853F-00C4B4FA97E7Q30371711-69D4281D-AA1B-48EC-BA23-7181B2DB4102Q33745258-FEDB1042-4A84-4FAB-8B39-38F025DF0FF4Q33801996-13B0C794-C050-473D-A814-479D1CDA0616Q33897820-1BCA8442-24C7-45E1-B979-1698E727027EQ34140523-6ACB465B-55CA-49A5-8544-0883EE8FE3E3Q34478386-A0667A75-9EBF-43C2-92F3-AA8EB49276D6Q34509937-1BFEE922-51A0-4B39-B7AB-51E784374201Q35019101-55FCDA78-0236-4F7A-8133-FEC724719A5AQ35134926-3ACD9583-4481-4D0C-BA0A-6F406D53D782Q35510227-6AD2F2B1-6C18-4D96-9928-97D36D12CD44Q35820417-5429A440-C613-40E9-BE46-0A33F4B56B8AQ36094915-FC314EA2-5D44-4102-AF85-A9BBA591C789Q36147718-C0ED816F-09FB-46F8-9E64-429CEAA9F9F0Q36147789-59BF3AE9-6D1F-475E-BAF4-5BBEAFF647CCQ36563301-0AED99CF-86AC-4125-B134-3F864B6FA3A9Q36841145-71EC7A68-3E59-49FC-8037-0F9DEBB53B4EQ37108013-584EC8F5-1A36-4450-A0E2-FA4B1D85C276Q37207504-050A2A8B-F457-44FD-AE25-76F1D8D8DF18Q37240967-FD33B31A-68C5-421F-984F-5427747B13EEQ37251621-19EAD49E-A10F-448A-BCAB-63BCAF35CDD8Q37354021-FCC4320A-0A69-46A0-B90A-D41CF7857882Q37509530-C9EFECCF-BFBB-4EF0-9E2B-386D01E9FD9BQ37634313-82935101-FEE7-4DE2-A236-076343C510FCQ37672234-BF838804-B2E1-4B38-BB19-11568BA3B25DQ38010463-AA80B9A5-AD52-482E-B99C-C27D42287A6EQ38029792-A7104BF1-B7D9-41C8-9F9E-46A71695B6E3Q38149877-5B254400-6744-457C-AE38-C51AAB9E359CQ38187446-60EA117A-F241-4DA8-BE68-542F9648A999Q38233632-D022109C-CC29-48B5-B323-D548E4C04F67Q38235144-767964DF-4364-4080-B542-666FC124AC6BQ38433669-F2D67AEF-D561-4A54-9904-6B55E536DBD2Q38793388-87BF6880-5881-4F99-AAE3-813EAA8F206EQ39104962-B6C76346-B6C9-4719-969F-201D3DCBFCEEQ39407438-3C712E05-0AAF-40D2-A768-33801EF67366Q39419931-F1A37D1E-E6C1-47F9-AFDF-7CA818744019Q40072169-E400E92A-0EA6-4476-9261-A92F3087142AQ40563763-130B45B0-F4F2-4580-BF5B-AE5E40E8824C
P2860
Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Revised classification/nomencl ...... l Issues Consensus Conference.
@ast
Revised classification/nomencl ...... l Issues Consensus Conference.
@en
type
label
Revised classification/nomencl ...... l Issues Consensus Conference.
@ast
Revised classification/nomencl ...... l Issues Consensus Conference.
@en
prefLabel
Revised classification/nomencl ...... l Issues Consensus Conference.
@ast
Revised classification/nomencl ...... l Issues Consensus Conference.
@en
P2093
P2860
P50
P1476
Revised classification/nomencl ...... l Issues Consensus Conference.
@en
P2093
C Silva de Castro
I C Le Poole
I Katayama
L Benzekri
P2860
P356
10.1111/J.1755-148X.2012.00997.X
P577
2012-05-01T00:00:00Z